Differential PIAS3 expression in human malignancy
- PMID: 15138572
Differential PIAS3 expression in human malignancy
Abstract
STAT3 mediated signaling pathways can be inhibited by PIAS3 (protein inhibitor of activated STAT3), which was recently found to regulate protein stability and function by its SUMO (small-ubiquitin like modifiers) ligase activity in promoting sumoylation of important nuclear proteins. Over-expression of PIAS3 can induce apoptosis in prostate cancer cell lines both in vitro and in vivo. Checking endogenous PIAS3 expression in various human specimens by immunohistochemistry, we report that basal amounts of PIAS3 exist in the nucleus in a majority of epithelial and endothelial cells. Increased PIAS3 expression was observed in 100/103 samples examined in a variety of human cancers including lung, breast, prostate, colon-rectum, and brain tumors. Differential PIAS3 expression and the specific patterns may be useful as a molecular marker of human cancer.
Similar articles
-
[Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].Zhonghua Yi Xue Za Zhi. 2008 Feb 5;88(6):419-21. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18581899 Chinese.
-
Peroxisome proliferator-activated receptor- gamma expression in human malignant and normal brain, breast and prostate-derived cells.Prostaglandins Leukot Essent Fatty Acids. 2001 Apr-May;64(4-5):241-5. doi: 10.1054/plef.2001.0266. Prostaglandins Leukot Essent Fatty Acids. 2001. PMID: 11418018
-
TRIM8 modulates STAT3 activity through negative regulation of PIAS3.J Cell Sci. 2010 Jul 1;123(Pt 13):2238-45. doi: 10.1242/jcs.068981. Epub 2010 Jun 1. J Cell Sci. 2010. PMID: 20516148
-
The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.Biochim Biophys Acta. 2013 Nov;1834(11):2242-58. doi: 10.1016/j.bbapap.2013.01.029. Epub 2013 Jan 31. Biochim Biophys Acta. 2013. PMID: 23376433 Review.
-
Cutaneous Metastasis of Internal Tumors.Dermatol Clin. 2019 Oct;37(4):545-554. doi: 10.1016/j.det.2019.05.012. Epub 2019 Jul 10. Dermatol Clin. 2019. PMID: 31466594 Review.
Cited by
-
SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation.J Proteome Res. 2023 Mar 3;22(3):812-825. doi: 10.1021/acs.jproteome.2c00557. Epub 2023 Feb 1. J Proteome Res. 2023. PMID: 36723483 Free PMC article.
-
Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.Int J Mol Sci. 2022 Jul 20;23(14):8012. doi: 10.3390/ijms23148012. Int J Mol Sci. 2022. PMID: 35887358 Free PMC article. Review.
-
PIAS3/SOCS1-STAT3 axis responses to oxidative stress in hepatocellular cancer cells.Am J Transl Res. 2021 Nov 15;13(11):12395-12409. eCollection 2021. Am J Transl Res. 2021. PMID: 34956461 Free PMC article.
-
PIAS3 suppresses damage in an Alzheimer's disease cell model by inducing the STAT3-associated STAT3/Nestin/Nrf2/HO-1 pathway.Mol Med. 2021 Nov 27;27(1):150. doi: 10.1186/s10020-021-00410-3. Mol Med. 2021. PMID: 34837964 Free PMC article.
-
SUMOylation Wrestles With the Occurrence and Development of Breast Cancer.Front Oncol. 2021 Apr 21;11:659661. doi: 10.3389/fonc.2021.659661. eCollection 2021. Front Oncol. 2021. PMID: 33968766 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
